BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 941952)

  • 1. Estrogen potencies of three new low-dose oral contraceptives.
    Dickey RP; Chihal HJ; Peppler RD
    Am J Obstet Gynecol; 1976 Aug; 125(7):976-9. PubMed ID: 941952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen potency of oral contraceptive pills.
    Chihal HJ; Peppler RD; Dickey RP
    Am J Obstet Gynecol; 1975 Jan; 121(1):75-83. PubMed ID: 1115120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
    Ayangade O; Akinyemi A
    Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized double blind study of two oral contraceptives.
    Sanhueza H; Sivin I; Kumar S; Kessler M; Carrasco A; Yee J
    Contraception; 1979 Jul; 20(1):29-48. PubMed ID: 477315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of Norinyl and Brevicon in three sites in Sri Lanka.
    Basnayake S; de Silva SV; Miller PC; Rogers S
    Contraception; 1983 May; 27(5):453-64. PubMed ID: 6884024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative trials of low-dose combined oral contraceptives.
    Edelman DA; Kothenbeutel R; Levinski MJ; Kelly SE
    J Reprod Med; 1983 Mar; 28(3):195-200. PubMed ID: 6854550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
    Damber MG; von Schoultz B; Solheim F; Stigbrand T
    Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of the side effects of switching from one oral contraceptive to another.
    Edelman DA; Kothenbeutel R; Levinski MJ; Talwar PP
    Int J Gynaecol Obstet; 1976; 14(5):397-400. PubMed ID: 15904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
    Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral contraceptive agents on nutrients: II. Vitamins.
    Prasad AS; Oberleas D; Moghissi KS; Stryker JC; Lei KY
    Am J Clin Nutr; 1975 Apr; 28(4):385-91. PubMed ID: 1168019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial control: a comparative study of three oral contraceptives.
    Talwar PP; Dingfelder JR; Ravenholt RT
    Int J Gynaecol Obstet; 1976; 14(5):385-9. PubMed ID: 15901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral alanine loads on plasma amino acids in oral contraceptive users and control women.
    Potera C; Rose DP
    Am J Clin Nutr; 1978 May; 31(5):794-8. PubMed ID: 645627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of three oral contraceptives in Ibadan: Norinyl 1/35, Lo-Ovral and Noriday 1/50.
    Otolorin EO; Falase EA; Ladipo OA
    Afr J Med Med Sci; 1990 Mar; 19(1):15-22. PubMed ID: 2109515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.